4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-025000
Chief Executive Officer sold 18,360 shares at $55.21 ($1,013,564)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2025-02-19 | Sale 10b5-1 | −18,360 | $55.21 | $1,013,564 | 171,613 | D: show line 1 in the form |
| Open-market sales · 18,360 sh · avg $55.21 · $1,013,564 | |||||||
Loading xslF345X05/ownership.xml…